Sarepta Therapeutics shares plunged 36% after the company reported a second case of acute liver failure resulting in death from taking Elevidys, which is a gene therapy for patients with Duchenne ...

The Japanese company has already committed to heavy investment in U.S. Steel and a U.S.-controlled board of directors at the ...

President Donald Trump would have unique influence over the operations of U.S. Steel under the terms of the investment being ...